Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant

Hyacinth Browne, Alicia Armstrong, Alan DeCherney, Rebecca Babb, Gabor Illei, James Segars, Steven Pavletic

Research output: Contribution to journalArticlepeer-review

Abstract

In this small pilot study, anti-Müllerian hormone (AMH) levels in women undergoing chemotherapy and hematopoietic stem cell transplantation facilitated earlier identification of impaired ovarian reserve compared with FSH and the resumption of menses. Larger studies are needed to accurately assess the clinical significance of AMH levels in the prediction of long-term reproductive outcomes in reproductive-age transplant patients with our current conditioning regimen.

Original languageEnglish (US)
Pages (from-to)1529-1532
Number of pages4
JournalFertility and sterility
Volume91
Issue number4 SUPPL.
DOIs
StatePublished - Apr 2009
Externally publishedYes

Keywords

  • Stem cell transplant
  • anti-Müllerian hormone
  • ovarian reserve

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant'. Together they form a unique fingerprint.

Cite this